EichorEICHOR
Location: Worcester Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Worcester

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · University of Massachusetts Medical School · Eli Lilly and Company · NCT07218380Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · UMass Memorial Medical Center · Joseph Broderick, MD · NCT07227246Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
NA · University of Massachusetts Medical School · University of Massachusetts, Worcester · NCT06278922MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · UMass Memorial Medical Center - University Campus · National Cancer Institute (NCI) · NCT05564390Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data
Phase N/A · University of Massachusetts Medical School · Sanofi · NCT07094373A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · UMass Memorial Medical Center - Belmont Street /ID# 272122 · AbbVie · NCT06682988Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · UMass Memorial Medical Center - University Campus · NRG Oncology · NCT05624996A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Phase N/A · University of Massachusetts Chan Medical School · ITF Therapeutics LLC · NCT07127978Early Detection of Gestational Diabetes Mellitus in Pregnancy
NA · University of Massachusetts Memorial Medical Center · University of Massachusetts, Worcester · NCT05388643A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0059 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · UMass Memorial Medical Center - University Campus · National Cancer Institute (NCI) · NCT05691478A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Local Institution - 0059 · Bristol-Myers Squibb · NCT07288567Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Worcestershire Royal Hospital · Amgen · NCT07037433A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis
Phase 4 · UMass Memorial Medical Center · argenx · NCT06909214A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · University of Massachusetts Worcester · Deciphera Pharmaceuticals, LLC · NCT05957367Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Reliant Medical Group · Eli Lilly and Company · NCT06890598SELUTION4BTK Trial
NA · University of Massachusetts Medical Center · M.A. Med Alliance S.A. · NCT05055297A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Phase 3 · UMass Memorial Medical Center · Krystal Biotech, Inc. · NCT07016750A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · UMass Memorial Medical Center - University Campus · Children's Oncology Group · NCT04322318A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal
NA · UMASS · RedDress Ltd. · NCT05641844Nectero EAST System Clinical Study
Phase 2/Phase 3 · University of Massachusetts · Nectero Medical, Inc. · NCT06001918Preventing T2DM After GDM With Immediate Postpartum Screening
NA · University of Massachusetts Memorial Medical Center · University of Massachusetts, Worcester · NCT06457139Individualizing Treatment for Asthma in Primary Care (Full Study)
Phase 4 · Reliant Medical Group · DARTNet Institute · NCT07052942Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · University of Massachusetts · Kura Oncology, Inc. · NCT07007312Zenith® Fenestrated+ Clinical Study
NA · University of Massachusetts · Cook Research Incorporated · NCT04875429Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
NA · University of Massachusetts Chan Medical School · Dartmouth-Hitchcock Medical Center · NCT06425029A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax,
Phase 1 · UMass Chan Medical School · Kura Oncology, Inc. · NCT05735184Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · UMass/Shields · SOFIE · NCT07217717Promoting Early Intervention Timing and Attention to Language
NA · University of Massachusetts Medical Center · University of California, Los Angeles · NCT05853861
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.